GlassScriptPhysician profile
Glenn M Kidder
NPI 1952453425
$1,248.63
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.64 · 2021: $116 · 2022: $319 · 2023: $493 · 2024: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $434.20 | 2022-2024 | Austedo Xr, Austedo |
| Biogen, INC. | $199.52 | 2020-2024 | Leqembi |
| Merz Pharmaceuticals, LLC | $159.52 | 2021-2023 | Xeomin |
| Kerr Corporation | $146.44 | 2023 | Endodontics |
| Nobel Biocare USA | $146.42 | 2023 | Nobelactive |
| Envista Holdings Corporation | $47.04 | 2024 | Endodontics |
| Impel Pharmaceuticals INC. | $35.64 | 2022-2023 | Trudhesa |
| Ucb, INC. | $20.40 | 2023 | Briviact |
| Ani Pharmaceuticals, INC. | $18.84 | 2024 | Purified Cortrophin Gel |
| Emd Serono, INC. | $15.97 | 2022 | |
| Currax Pharmaceuticals LLC | $13.61 | 2020 | |
| Ultradent Products INC | $11.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Kidder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.